{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:05:16Z","timestamp":1793639116817,"version":"4.5.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajo.2022.03.027","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:28:50Z","timestamp":1648927730000},"page":"239-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy"],"prefix":"10.1016","volume":"240","author":[{"given":"David T.","family":"Tse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale W.","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-9219","authenticated-orcid":false,"given":"Brian C.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Feuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0001","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(85)34081-2","article-title":"A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland","volume":"92","author":"Lee","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.03.027_bib0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archopht.116.5.613","article-title":"Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases","volume":"116","author":"Font","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0003","series-title":"Ocular and Adnexal Tumors","first-page":"787","article-title":"Epithelial tumors of the lacrimal gland: an analysis of 265 cases","author":"Font","year":"1978"},{"key":"10.1016\/j.ajo.2022.03.027_bib0004","series-title":"Ocular Pathology. Update","first-page":"277","article-title":"Adenoid cystic carcinoma of the lacrimal gland. A clinicopathologic study of 79 cases","author":"Font","year":"1980"},{"issue":"3","key":"10.1016\/j.ajo.2022.03.027_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0046-8177(82)80180-9","article-title":"Adenoid cystic carcinoma of the lacrimal gland: the clinical significance of a basaloid histologic pattern","volume":"13","author":"Gamel","year":"1982","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.ajo.2022.03.027_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.63.9.600","article-title":"Clinical presentation and management of lacrimal gland tumours","volume":"63","author":"Wright","year":"1979","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9394(75)90455-9","article-title":"Combined therapeutic approach to malignant lacrimal gland tumors","volume":"79","author":"Byers","year":"1975","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0008","first-page":"3","article-title":"Factors affecting the survival of patients with lacrimal gland tumours","volume":"17","author":"Wright","year":"1982","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0009","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/bjo.70.10.727","article-title":"Past, present, and future surgical management of malignant epithelial neoplasms of the lacrimal gland","volume":"70","author":"Henderson","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002341-199403000-00009","article-title":"Adenoid cystic carcinoma of the lacrimal gland: a case report","volume":"10","author":"Naugle","year":"1994","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.ajo.2022.03.027_bib0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004397-198202210-00009","article-title":"Lacrimal gland tumors: a clinicopathological analysis of 160 cases","volume":"22","author":"Ni","year":"1982","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajo.2022.03.027_bib0012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9394(75)90455-9","article-title":"Combined therapeutic approach to malignant lacrimal gland tumors","volume":"79","author":"Byers","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0013","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0002-9394(76)90068-4","article-title":"En bloc removal of intrinsic neoplasms of the lacrimal gland","volume":"82","author":"Henderson","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0014","series-title":"Diseases of the Orbit; A Multidisciplinary Approach","first-page":"384","article-title":"Tumors of the lacrimal gland","author":"Rootman","year":"1988"},{"key":"10.1016\/j.ajo.2022.03.027_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00006534-198110000-00017","article-title":"Lacrimal gland adenoid cystic carcinoma: intracranial and extracranial en bloc resection","volume":"68","author":"Marsh","year":"1981","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ajo.2022.03.027_bib0016","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0002-9610(84)90384-2","article-title":"Surgical management of malignant tumors of the lacrimal gland","volume":"148","author":"Janecka","year":"1984","journal-title":"Am J Surg"},{"key":"10.1016\/j.ajo.2022.03.027_bib0017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.IOP.0000105518.72611.4F","article-title":"Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland","volume":"20","author":"Esmaeli","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.ajo.2022.03.027_bib0018","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.iop.0000232164.00208.b4","article-title":"Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland","volume":"22","author":"Esmaeli","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ajo.2022.03.027_bib0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IOP.0000000000001177","article-title":"Cranio-orbital resection does not appear to improve survival of patients with lacrimal gland carcinoma","volume":"35","author":"Rose","year":"2019","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ajo.2022.03.027_bib0020","first-page":"312","article-title":"Adenoid cystic carcinoma of the lacrimal gland, is there a cure?","volume":"85","author":"Henderson","year":"1987","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2022.03.027_bib0021","first-page":"314","article-title":"Discussion of Henderson JW. Adenoid cystic carcinoma of the lacrimal gland: is there a cure?","volume":"85","author":"Jakobiec","year":"1987","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2022.03.027_bib0022","first-page":"422","article-title":"Epithelial malignancies of the lacrimal gland: survival rates after extensive and conservative therapy","volume":"25","author":"Polito","year":"1993","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0023","first-page":"306","article-title":"Epithelial tumours of the lacrimal gland","volume":"14","author":"Ashton","year":"1975","journal-title":"Mod Probl Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0024","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004397-196206000-00005","article-title":"Epithelial tumors of the lacrimal gland: prognostic and therapeutic significance of histologic types","volume":"2","author":"Zimmerman","year":"1962","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajo.2022.03.027_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/bjo.76.7.401","article-title":"Primary malignant neoplasms of the lacrimal gland","volume":"76","author":"Wright","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0026","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ophtha.2013.05.006","article-title":"Adenoid Cystic Carcinoma of the Lacrimal Gland: Rare . . . Lethal . . . Cured?","volume":"120","author":"Bradley","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.03.027_bib0027","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archopht.116.3.315","article-title":"Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland","volume":"116","author":"Meldrum","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0028","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ajo.2022.03.027_bib0029","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/88.19.1346","article-title":"DNA repair: enzymatic mechanisms and relevance to drug response","volume":"88","author":"Chaney","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajo.2022.03.027_bib0030","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"Furuta","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajo.2022.03.027_bib0031","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0033","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ophtha.2013.01.027","article-title":"Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma","volume":"120","author":"Tse","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0034","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2005.08.068","article-title":"Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma","volume":"141","author":"Tse","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0035","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.ophtha.2013.11.012","article-title":"Author reply: To PMID 23582989","volume":"121","author":"Tse","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.03.027_bib0036","series-title":"AJCC Cancer Staging Manual","first-page":"569","author":"Edge","year":"2009"},{"key":"10.1016\/j.ajo.2022.03.027_bib0037","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/bmj.d6395","article-title":"Should we use total mortality rather than cancer-specific mortality to judge cancer screening programmes? Yes","volume":"343","author":"Penston","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2022.03.027_bib0038","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1136\/bmj.d6397","article-title":"Should we use total mortality rather than cancer-specific mortality to judge cancer screening programmes?","volume":"343","author":"Steele","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajo.2022.03.027_bib0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2018.07.024","article-title":"Long-term outcomes of globe-preserving surgery with proton beam radiation for adenoid cystic carcinoma of the lacrimal gland","volume":"195","author":"Wolkow","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.03.027_bib0041","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/IOP.0000000000000877","article-title":"Long-term outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland, ophthalmic plastic and reconstructive surgery","volume":"34","author":"Han","year":"2018","journal-title":"Ophthalmic Plast Reconstructr Surg"},{"key":"10.1016\/j.ajo.2022.03.027_bib0044","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/cncr.26740","article-title":"A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry","volume":"118","author":"Li","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ajo.2022.03.027_bib0045","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.ophtha.2008.12.049","article-title":"American Joint Committee on Cancer classification predicts outcome of patients with lacrimal-gland adenoid cystic carcinoma","volume":"116","author":"Ahmad","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.03.027_bib0042","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajo.2005.08.070","article-title":"An atypical presentation of adenoid cystic carcinoma of the lacrimal gland","volume":"141","author":"Tse","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0047","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2214\/AJR.11.7420","article-title":"MRI of spinal bone marrow: Part 2, T1-weighted imaging-based differential diagnosis","volume":"197","author":"Hanrahan","year":"2011","journal-title":"AJR"},{"key":"10.1016\/j.ajo.2022.03.027_bib0048","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ejso.2007.11.001","article-title":"Fifteen years of bone cryosurgery: A single-center experience of 440 procedures and long-term follow-up","volume":"34","author":"Meller","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ajo.2022.03.027_bib0049","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(05)70023-1","article-title":"Cryosurgery in aggressive, benign, and low-grade malignant bone tumours","volume":"6","author":"Veth","year":"2005","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.ajo.2022.03.027_bib0050","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-15-1370","article-title":"Mechanisms of cancer cell dormancy \u2013 another hallmark of cancer?","volume":"75","author":"Yeh","year":"2015","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ajo.2022.03.027_bib0051","doi-asserted-by":"crossref","first-page":"480","DOI":"10.18632\/oncotarget.26558","article-title":"Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland","volume":"10","author":"Doddapaneni","year":"2019","journal-title":"Oncotarget"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:51:34Z","timestamp":1757598694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":48,"alternative-id":["S0002939422001362"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.03.027","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}